Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil E Martin

Showing results (91-100 of 123) with videos related to

Pageof 13
Sort By:
Cancer|December 13, 2017
Travel distance and stereotactic body radiotherapy for localized prostate cancerBrandon A Mahal, Yu-Wei Chen, Roshan V Sethi, et al.
The American Journal of Medicine|February 4, 2015
Who bears the greatest burden of aggressive treatment of indolent prostate cancer?Brandon A Mahal, Matthew R Cooperberg, Ayal A Aizer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 29, 2013
Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective studyKe Zu, Neil E Martin, Michelangelo Fiorentino, et al.
JNCI Cancer Spectrum|August 14, 2024
Cognitive function in long-term testicular cancer survivors: impact of modifiable factorsPaul C Dinh, Patrick O Monahan, Chunkit Fung, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate sizePaul L Nguyen, Ming H Chen, Toni K Choueiri, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2011
Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure or myocardial infarctionPaul L Nguyen, Ming-Hui Chen, Joshua A Beckman, et al.
Cancer|July 20, 2016
National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers?Brandon A Mahal, Yu-Wei Chen, Vinayak Muralidhar, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate CancerDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 19, 2025
CT online adaptive radiotherapy is associated with dosimetric and acute toxicity improvements in prostate cancer treatmentLin L Zhu, Jeremy S Bredfeldt, Yue-Houng Hu, et al.
Brachytherapy|May 9, 2013
Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancerArti Parekh, Ming-Hui Chen, Anthony V D'Amico, et al.
Pageof 13

Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Cancer|December 13, 2017
Travel distance and stereotactic body radiotherapy for localized prostate cancerBrandon A Mahal, Yu-Wei Chen, Roshan V Sethi, et al.
The American Journal of Medicine|February 4, 2015
Who bears the greatest burden of aggressive treatment of indolent prostate cancer?Brandon A Mahal, Matthew R Cooperberg, Ayal A Aizer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 29, 2013
Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective studyKe Zu, Neil E Martin, Michelangelo Fiorentino, et al.
JNCI Cancer Spectrum|August 14, 2024
Cognitive function in long-term testicular cancer survivors: impact of modifiable factorsPaul C Dinh, Patrick O Monahan, Chunkit Fung, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate sizePaul L Nguyen, Ming H Chen, Toni K Choueiri, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2011
Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure or myocardial infarctionPaul L Nguyen, Ming-Hui Chen, Joshua A Beckman, et al.
Cancer|July 20, 2016
National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers?Brandon A Mahal, Yu-Wei Chen, Vinayak Muralidhar, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate CancerDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 19, 2025
CT online adaptive radiotherapy is associated with dosimetric and acute toxicity improvements in prostate cancer treatmentLin L Zhu, Jeremy S Bredfeldt, Yue-Houng Hu, et al.
Brachytherapy|May 9, 2013
Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancerArti Parekh, Ming-Hui Chen, Anthony V D'Amico, et al.
Pageof 13